Upload
donald-laundry
View
218
Download
0
Tags:
Embed Size (px)
Citation preview
Laser Intervention in Early Age Related Macular Degeneration
Emily Caruso – LEAD trial Coordinator
AMD
Macular degeneration is one of the leading causes of blindness in Australia.
Stages of AMD
• Early AMD
• Wet AMD Dry AMD
• Currently there is only treatment for WET macular degeneration.
• Lucentis• Eylea
Treatment
Early AMD
• Vision is good• Drusen present• Diagnosis usually picked
up on routine visit to the Optometrist.
• No signs of any late AMD progression
2RT nanosecond laser- Ellex
• Speckled effect Laser– Killing sick RPE cells
• Healthy cells will divide, and bridge over the gap the laser has left
• New cells will function to clear away the debris in Bruch's Membrane.
• Gentle laser• Doesn’t leave burns(like current lasers do)• Painless.
2RT Pilot study
• The world first Pilot study of the Ellex nanosecond laser in the treatment of Early AMD ran for 3 years.
• 50 Participants• All had 1 eye treated with the2RT nanosecond laser
2RT Pilot study results
• Reduction in Drusen• Improved Macular Function–We are seeing these results in not only the
treated eye but in some cases the fellow non-treated eye
Drusen Regression• Baseline 9 months
Bilateral Effect
• Right Eye Baseline RE 3 months post laser to LE
Bilateral Effect • Before Treatment to LE 3 months post laser to LE
Bilateral Effect
• Before laser to RE
• 12 months afterLaser to RE
LEAD STUDY
• With positive results from the Pilot study, we received an NHMRC grant to conduct the worlds first multi centred randomised control trial of nanosecond laser in the treatment of early AMD. (LEAD Trial)
LEAD Study
Aim: To provide an Early intervention, which may slow or partially reverse the progression of the disease, before any late changes develop.
LEAD Update
• Recruitment will finish at the end of 2014.
• Aiming to have 150 participants at the RVEEH site.
• Overall recruitment aim is 350 participants.
• Multiple sites recruiting.– Melbourne (2 sites)– Sydney– Adelaide– Perth– Northern Ireland
LEAD Inclusion criteria
• Bilateral high-risk early AMD
• Best corrected VA 6/12 or better in each eye
• 50-95 years of age• MAIA perimetry result
of <25 dB in one eye in the same area on 2 tests
THANK YOU!
• Any Questions